Clinical Trial Update: Natrecor in Pulmonary Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Natrecor in pulmonary hypertension; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiothoracic Surgery
• Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pulmonary Hypertension, Cancer | Phase 4 | Status: TERMINATED